717 related articles for article (PubMed ID: 10365929)
1. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.
Kaddu S; Zenahlik P; Beham-Schmid C; Kerl H; Cerroni L
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):966-78. PubMed ID: 10365929
[TBL] [Abstract][Full Text] [Related]
2. CD56+ blastic transformation of chronic myeloid leukemia involving the skin.
Kaddu S; Beham-Schmid C; Zenahlik P; Kerl H; Cerroni L
J Cutan Pathol; 1999 Nov; 26(10):497-503. PubMed ID: 10599940
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous infiltrates of acute myelogenous leukemia simulating inflammatory dermatoses.
Martínez-Escanamé M; Zuriel D; Tee SI; Fried I; Massone C; Cerroni L
Am J Dermatopathol; 2013 Jun; 35(4):419-24. PubMed ID: 23221486
[TBL] [Abstract][Full Text] [Related]
4. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients.
Cerroni L; Zenahlik P; Höfler G; Kaddu S; Smolle J; Kerl H
Am J Surg Pathol; 1996 Aug; 20(8):1000-10. PubMed ID: 8712287
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies.
Horny HP; Wehrmann M; Steinke B; Kaiserling E
Hum Pathol; 1994 Aug; 25(8):810-4. PubMed ID: 8056422
[TBL] [Abstract][Full Text] [Related]
6. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia arising at the site of herpes zoster and herpes simplex scars.
Cerroni L; Zenahlik P; Kerl H
Cancer; 1995 Jul; 76(1):26-31. PubMed ID: 8630873
[TBL] [Abstract][Full Text] [Related]
7. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
Kaiserling E; Horny HP; Geerts ML; Schmid U
Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
[TBL] [Abstract][Full Text] [Related]
8. Specific skin manifestations in acute leukemia with monocytic differentiation. A morphologic and immunohistochemical study of 11 cases.
Sepp N; Radaszkiewicz T; Meijer CJ; Smolle J; Seewann H; Fritsch P; Kerl H
Cancer; 1993 Jan; 71(1):124-32. PubMed ID: 8416708
[TBL] [Abstract][Full Text] [Related]
9. Leukemia cutis from CD56 positive, myeloperoxidase negative acute myeloid leukemia.
Abdou AG; Seleit I; Bakry OA; Abdel-Wahed MM
Acta Dermatovenerol Croat; 2013; 21(3):189-92. PubMed ID: 24183224
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed, paraffin-embedded tissue.
Hudock J; Chatten J; Miettinen M
Am J Clin Pathol; 1994 Jul; 102(1):55-60. PubMed ID: 8037168
[TBL] [Abstract][Full Text] [Related]
11. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
12. Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers.
Ratnam KV; Su WP; Ziesmer SC; Li CY
J Cutan Pathol; 1992 Jun; 19(3):193-200. PubMed ID: 1383298
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
[TBL] [Abstract][Full Text] [Related]
14. Leukemia cutis as the presenting symptom of acute myeloid leukemia: report of three cases.
Moyer AB; Rembold J; Lee NE; Johnson G; Gardner JM
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142735
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of myeloid leukemia cutis.
Li L; Wang Y; Lian CG; Hu N; Jin H; Liu Y
An Bras Dermatol; 2018 Mar; 93(2):216-221. PubMed ID: 29723350
[TBL] [Abstract][Full Text] [Related]
16. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
Villiers E; Baines S; Law AM; Mallows V
Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
[TBL] [Abstract][Full Text] [Related]
17. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
18. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
[TBL] [Abstract][Full Text] [Related]
20. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
